Cite

HARVARD Citation

    Li, J. et al. (2016). Targeted antitumor prodrug therapy using CNGRC-yCD fusion protein in combination with 5-fluorocytosine. Journal of biomedical science. 23 (1), pp. 1-10. [Online]. 
  
Back to record